A Phase 2, Randomized, Placebo-Controlled, Dose-Ranging Study Of PF-00489791 In Subjects With Stage 1 And 2 Essential Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)

Trial Profile

A Phase 2, Randomized, Placebo-Controlled, Dose-Ranging Study Of PF-00489791 In Subjects With Stage 1 And 2 Essential Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2009

At a glance

  • Drugs PF 489791 (Primary)
  • Indications Essential hypertension; Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Feb 2008 Status change from in progress to completed, as reported by clinicaltrials.gov.
    • 11 Jan 2008 Status change from recruiting to in progress.
    • 28 Dec 2007 The expected completion date for this trial is now 1 Jan 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top